Terms ending in 2039
Every in-force patent on Sunovion Pharmaceuticals Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,815,249 | Salts, Crystal Forms, and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | |
| US 11,440,921 | Salts, Crystal Forms, and Production Methods Thereof In force · High confidence | Sunovion Pharmaceuticals Inc. | In force | High confidence | |
| US 11,987,591 | Salts, Crystal Forms, and Production Methods Thereof In force · Medium confidence | Sumitomo Pharma America, Inc. | In force | Medium confidence |
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Sunovion Pharmaceuticals Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.